Mayo Clinic researchers have developed a promising new way to deliver treatment directly to cholangiocarcinoma tumors, a rare and aggressive bile duct cancer with limited treatment options, using milk ...

Mayo Clinic researchers used milk-based nanoparticles to deliver siRNA into bile duct cancer cells. This targeted therapy ...

The findings, published in JHEP Reports, point to a potential targeted genetic therapy designed to attack cancer cells while ...

Mayo Clinic researchers have developed a promising new way to deliver treatment directly to cholangiocarcinoma tumors, a rare ...

His diagnosis came the day before his pregnant partner’s 20-week scan for their first baby ...

Lynavoy is used to treat cholestatic pruritus, an extreme itch that affects almost 90% of patients with primary biliary cholangitis.

In this study, researchers aimed to determine whether the addition of durvalumab to gemcitabine plus cisplatin increases time toxicity.

The family of a new dad who died from bile-duct cancer have hit out at health officials who rejected the use of a potentially life-saving treatment on the NHS. Huw Jones, 33, from North Wales, died in ...

A surgeon who took a new drug under clinical trial during cancer treatment is calling on the NHS to approve the drug to tackle ‘inequalities in care’.

The content creator, 26, was diagnosed with a rare bile duct cancer nearly three years ago ...

The biliary tract cancer market is experiencing steady growth driven by rising global incidence and improved diagnostic ...